World PGx

Organization: Hanson Wade

Venue: Hotel Monaco

Location: San Francisco, California, United States

Event Date/Time: Apr 30, 2013 End Date/Time: May 02, 2013
Report as Spam



Decoding drug response to advance your personalized medicine programs

Recent ENCODE data has further highlighted the importance of genomic research in the ongoing development of personalized treatments. This new wave of understanding the human genome and its role in drug response is having implications far beyond the halls of academia, and is having a hugely significant effect on the way we view personalized drug development

If you’re reading this, you’re probably already tapping into the huge commercial potential of PGx. But you’ll also agree that there are many unanswered questions. For instance, the integration of genetics into drug discovery and development.How pharmacogenomics can better influence the course of clinical development? And of course, how to effectively and practically utilize genomic information now?

How will World PGx help you answer these questions?

More effectively predict patient response

  • Hear the latest clinical and commercial case studies from Big pharma, including GlaxoSmithKlineTakedaPfizerMerckGileadClovis OncologyRoche and Bristol Myers Squibb, and learn how these companies are successfully using drug response data to guide clinical development
  • Take part in highly focused Mastermind Groups – build your knowledge of the PGx landscape through interactive sharing
  • Interactive pre-conference workshops give you the tools you need to take your own projects to the next level, by learning how to make better use of predictive biomarkers

Make better use of genetic data

  • Learn about the cutting edge technology innovations driving pharmacogenomics in drug development, in NGS, PCR, GWAS and more
  • Leading bioinformatics experts from Gilead, plus World-class academics fromDana Farber, and the University of Michigan will present information ongenomic data handling, stratification and profiling strategies, andoptimizing pharmacogenetic studies, to allow for maximum efficacy in the clinic
  • Michael SnyderDirector of the Center for Genomics and Personalized Medicine at Stanford, shares real-life experiences  of the impact of sequencing data on healthcare

Develop better drugs

  • Network with the leading solutions providers looking to develop the strong co-development partnerships driving personalized medicine development
  • The latest on the FDA guidance affecting PGx and diagnostic development and commercialization: Get practical information on how this will affect your business
  • Explore and discuss the future of pharmacogenomics in drug development, spend time with your peers and potential partners, share knowledge and help create a roadmap for the future of personalized genomic medicine 

Plus over 8 hours of dedicated networking opportunities, meaning you get to spend quality time with the key players in the PGx field

 |  | 


Hotel Monaco
501 Geary Street
United States


Hanson Wade